	Validation and limitations of the distress thermometer in identifying depression among metastatic breast cancer patients in Nigeria: Methodological challenges in depression-specific screening validation. PLoS One Chavda T, Lawal A, Sowunmi A, Adegboyega B, Alabi A, Chung CC, Shirima S, Conserve DF, Bamodu OA. PMID: 41557711 [PubMed - indexed for MEDLINE]
	Zwitterionic molecularly imprinted polymers for selective capillary microextraction of N1,N12-Diacetylspermine (DiAcSpm) from breast cancer. PLoS One Ying K, Xue H, Du S, Wang X, Lei X. PMID: 41557635 [PubMed - indexed for MEDLINE]
	Five-Year Absolute Risk-Based and Age-Based Breast Cancer Screening in the US. JAMA Netw Open Alagoz O, Lu Y, Gil Quessep E, Kerlikowske K, Mandelblatt JS, Sprague BL, Trentham-Dietz A, Hampton J, Groeneweg R, de Koning HJ, Miglioretti DL, Schechter CB, van Ravesteyn NT, Tosteson ANA, Stout NK, Lowry KP. PMID: 41557352 [PubMed - indexed for MEDLINE]
	Exosomal crosstalk between breast cancer cells and tumor-associated macrophages: mechanisms and therapeutic implications. Mol Biol Rep Gong RQ, Xu A, Huang X, Fu D. PMID: 41557096 [PubMed - in process]
	Fracture risk in metastatic breast cancer patients treated with CDK 4/6 inhibitors and endocrine therapy. Breast Cancer Res Treat Pedersini R, Moretti L, Laganà M, Schivardi G, Baluta V, Zamparini M, Conforti E, Ravanelli M, Brentegani C, Amoroso V, Grisanti S, Buizza C, Scartabellati G, Bazzoli M, Ippolito G, Pellicioli F, Farina D, Berruti A, Cosentini D. PMID: 41557073 [PubMed - indexed for MEDLINE]
	Response to letter to the editor: Risk of endometrial cancer among breast cancer survivors in Japan-a matched cohort study. Breast Cancer Kawamura C, Iwagami M. PMID: 41557052 [PubMed - as supplied by publisher]
	Real-world outcomes of reduced-dose versus standard-dose antibody drug conjugates in metastatic breast cancer: a retrospective cohort study. Breast Cancer Res Treat Stabellini N, Kaur J, Owusu C, Moftakhar B, Mizukami T, de Oliveira SD, Montero AJ. PMID: 41557039 [PubMed - indexed for MEDLINE]
	Translational and real-world evidence of trastuzumab biosimilar CT-P6 plus pertuzumab in neoadjuvant HER2-positive early breast cancer. Breast Cancer Res Treat Alonso-Romero JL, Martínez-García J, Carrillo-Vicente R, Aramburo AF, Díez AF, Henarejos PS, de la Morena Barrio P, Boix AP, Jiménez MD, Siles JP, Maestre JAP, de Las Heras-Rubio A, Carreño PR. PMID: 41557021 [PubMed - indexed for MEDLINE]
	Integrated multi-omics identifies MCRS1 as a causal hub linking aging, metabolic syndrome, and breast cancer progression. Int J Surg Tao Y, Ding X, Xuan W, Zhu H, Liu X, Chen Y, Wu J, Du J, Tian J, Qian G. PMID: 41556158 [PubMed - as supplied by publisher]
	Triple HER2 Blockade With Trastuzumab, Pertuzumab, and Pyrotinib Versus Dual HER2 Blockade in the Neoadjuvant Treatment of HER2-Positive Breast Cancer: A Randomized, Phase II Study. MedComm (2020) Huang J, Wang H, Tong Y, Hong J, Zhu Y, Ren W, Yu J, Shi H, Gao W, Zhu S, Wu J, Huang O, Li J, He J, Chen W, Li Y, Shen K, Chen X. PMID: 41556040 [PubMed]
	Potential Targets and Biomarkers of Radionuclide Therapy in Breast Cancer. Cancer Innov Tan Y, Zeng C, Wang J, Ma F. PMID: 41555955 [PubMed]
	Maternal Obesity and MicroRNAs in Breast Milk: Implications for Infant Developmental Programming. Obes Rev Santos GM, de Souza FIS, Pisani LP. PMID: 41555688 [PubMed - as supplied by publisher]
	Opioids in breast cancer: Between analgesia and modulation of tumour progression. Br J Pharmacol Ciwun M, Tankiewicz-Kwedlo A, Pawlak D. PMID: 41555671 [PubMed - as supplied by publisher]
	Efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy in breast cancer: a systematic review and meta-analysis with focus on triple-negative subtype and immune-related adverse events. BMC Cancer Aikelaimu A, Li W, Kaicaier M, Liu S, Zhang Y, Hou X, Wang Y, Ma L, Jiang W. PMID: 41555292 [PubMed - as supplied by publisher]
	Breast Surgical Perspectives on the NSABP B-51/RTOG 1304 Trial on Omission of Regional Nodal Irradiation After Response to Neoadjuvant Chemotherapy. Ann Surg Oncol Kantor O, Woodfin AA, Specht M, Society of Surgical Oncology Breast Disease Site Working Group. PMID: 41555134 [PubMed - as supplied by publisher]
	The Critical Role of Dose Homogeneity in Modern Breast Hypofractionation. Int J Radiat Oncol Biol Phys Sourial F, Champ C, Beriwal S. PMID: 41554414 [PubMed - as supplied by publisher]
	The impact of prescribed versus achieved resistance training intensity on strength, body composition, and psychological health in women survivors of breast cancer: Protocol for the EFICAN 2.0 randomized trial. Contemp Clin Trials Esteban-Simón A, Díez-Fernández DM, Baena-Raya A, Pérez-Castilla A, Rodriguez-Solana A, Teodoro MR, Pérez-Romero A, Rodríguez-Pérez MA, Soriano-Maldonado A. PMID: 41554334 [PubMed - as supplied by publisher]
	Proteomics Study of Breast Cancer-Derived Small Extracellular Vesicles: Unveiling Potential Cancer Biomarkers. J Proteome Res Ngo CHL, Hnit SST, Zhang W, Feng X, Tan VIC, Hu L, Chang-Hao Tsao S, Wang Y. PMID: 41553850 [PubMed - as supplied by publisher]
	Can new ultrasound imaging techniques improve breast lesions characterization?: prospective comparison between ultrasound BI-RADS, histological result, semi-automatic software-"Live BreastAssist", strain elastography, shear wave elastography and microvascular flow. J Ultrasound Bonito G, Renda M, Gigli S, David E, Pacini P, Sili Scavalli A, Bella A, Lo Conte G, Rosini B, Shkelqimi A, D'Andrea V, Cantisani V, Pediconi F, Caiazzo C. PMID: 41553697 [PubMed - as supplied by publisher]
	Ferroptosis and its role in immune modulation in breast cancer. Apoptosis Liu F, Xiao JH, Song YJ, Zeng CC. PMID: 41553559 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 213737

Page 1 of 10687



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy